A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas

Conditions

Hemangioma

What is the purpose of this trial?

The purpose of this study is to evaluate the genotype of CTCF, a proven transcription factor, in patients with infantile hemangiomas and to monitor tumor growth. The investigators aim to determine whether or not the CTCF genotype might serve as an early and reliable predictor of tumor growth.



Participation Guidelines

Age:
Up to 1 Year
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
September 2009
Last Updated:
June 23, 2014
Study HIC#:
0507000430

Clinicaltrials.gov ID: NCT00974129